November 4 – 6 | The Westin City Center | Washington, D.C.
Daily registration allows Policy Summit attendees to choose the legislative, regulatory, and bioethical content that's most relevant to them, or to register for all three days for a full-scope experience. Registration closes on Oct. 30.
Register Online
November 4: Explore solutions to challenges experienced both by global regulators and by sponsors developing gene therapies across established and emerging markets.
November 5: Address the status of legislative and regulatory solutions to the primary challenges in paying for gene therapies for different payer types, as well as the current state of Medicaid reimbursement policies for these therapies.
November 6: Stakeholders discuss considerations surrounding germline gene editing, including current legal status for clinical research; recent proposals to limit clinical applications; and potential mechanisms necessary to achieve societal consensus.
Take advantage of ASGCT's daily registration to tailor your Policy Summit experience to your expertise, or register for all three days and take in the full scope of regulatory, payment, and bioethical issues surrounding gene and cell therapy. Registration closes on Oct. 30.
Support leaders in the scientific, regulatory, and bioethical communities by partnering with ASGCT to sponsor the ASGCT Policy Summit.
ASGCT has established a small room block at The Westin in Washington, D.C. for the duration of the 2019 Policy Summit. The ASGCT rate is $269 per night.
© 2000-2019 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico